| Dr Maricel A Isidro-reighard, CRNA | |
|
1700 Mount Vernon Ave, Anesthesia Department, Bakersfield, CA 93306-4018 | |
| (661) 578-7273 | |
| (661) 578-7273 |
| Full Name | Dr Maricel A Isidro-reighard |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 19 Years |
| Location | 1700 Mount Vernon Ave, Bakersfield, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144334368 | NPI | - | NPPES |
| RN0035270 | Medicaid | CA |
| Entity Name | Kern Valley Healthcare District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427049964 PECOS PAC ID: 8628069689 Enrollment ID: O20040519001345 |
News Archive
NeuroSigma, Inc., a California-based life-sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that it has received approval from the Therapeutic Goods Administration to market its Monarch eTNS System in Australia.
A recent study published in the February 2015 issue of the Journal of the American Academy of Child and Adolescent Psychiatry demonstrates that children who were abandoned to institutional care have an increased risk for behaviors similar to those seen in children with autism, including impaired social communication.
Obese and very obese patients have a lower risk of dying after they have been treated for heart attacks than do normal weight patients, according to research published in the European Heart Journal today (Wednesday 20 June).
"Lawyers for health insurers and the state sparred in court yesterday over regulators' rejection of 235 proposed rate increases, and a judge said he would decide by Monday whether the companies will be allowed to charge the higher prices." The insurers are arguing that the state's insurance commissioner overstepped his authority in rejecting the 235 of 274 requests to increase premiums (Weisman, 4/9).
› Verified 2 days ago
| Entity Name | Premier Anesthesia Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609880947 PECOS PAC ID: 2860472917 Enrollment ID: O20040825001711 |
News Archive
NeuroSigma, Inc., a California-based life-sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that it has received approval from the Therapeutic Goods Administration to market its Monarch eTNS System in Australia.
A recent study published in the February 2015 issue of the Journal of the American Academy of Child and Adolescent Psychiatry demonstrates that children who were abandoned to institutional care have an increased risk for behaviors similar to those seen in children with autism, including impaired social communication.
Obese and very obese patients have a lower risk of dying after they have been treated for heart attacks than do normal weight patients, according to research published in the European Heart Journal today (Wednesday 20 June).
"Lawyers for health insurers and the state sparred in court yesterday over regulators' rejection of 235 proposed rate increases, and a judge said he would decide by Monday whether the companies will be allowed to charge the higher prices." The insurers are arguing that the state's insurance commissioner overstepped his authority in rejecting the 235 of 274 requests to increase premiums (Weisman, 4/9).
› Verified 2 days ago
| Entity Name | Hullander And Mozingo Lp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164449880 PECOS PAC ID: 3971543752 Enrollment ID: O20050511000516 |
News Archive
NeuroSigma, Inc., a California-based life-sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that it has received approval from the Therapeutic Goods Administration to market its Monarch eTNS System in Australia.
A recent study published in the February 2015 issue of the Journal of the American Academy of Child and Adolescent Psychiatry demonstrates that children who were abandoned to institutional care have an increased risk for behaviors similar to those seen in children with autism, including impaired social communication.
Obese and very obese patients have a lower risk of dying after they have been treated for heart attacks than do normal weight patients, according to research published in the European Heart Journal today (Wednesday 20 June).
"Lawyers for health insurers and the state sparred in court yesterday over regulators' rejection of 235 proposed rate increases, and a judge said he would decide by Monday whether the companies will be allowed to charge the higher prices." The insurers are arguing that the state's insurance commissioner overstepped his authority in rejecting the 235 of 274 requests to increase premiums (Weisman, 4/9).
› Verified 2 days ago
| Entity Name | Wafik A Abdou Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114065968 PECOS PAC ID: 8426153537 Enrollment ID: O20070418000550 |
News Archive
NeuroSigma, Inc., a California-based life-sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that it has received approval from the Therapeutic Goods Administration to market its Monarch eTNS System in Australia.
A recent study published in the February 2015 issue of the Journal of the American Academy of Child and Adolescent Psychiatry demonstrates that children who were abandoned to institutional care have an increased risk for behaviors similar to those seen in children with autism, including impaired social communication.
Obese and very obese patients have a lower risk of dying after they have been treated for heart attacks than do normal weight patients, according to research published in the European Heart Journal today (Wednesday 20 June).
"Lawyers for health insurers and the state sparred in court yesterday over regulators' rejection of 235 proposed rate increases, and a judge said he would decide by Monday whether the companies will be allowed to charge the higher prices." The insurers are arguing that the state's insurance commissioner overstepped his authority in rejecting the 235 of 274 requests to increase premiums (Weisman, 4/9).
› Verified 2 days ago
| Entity Name | Resource Anesthesiology Assoc Of California, A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083746259 PECOS PAC ID: 6608974647 Enrollment ID: O20070614000336 |
News Archive
NeuroSigma, Inc., a California-based life-sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that it has received approval from the Therapeutic Goods Administration to market its Monarch eTNS System in Australia.
A recent study published in the February 2015 issue of the Journal of the American Academy of Child and Adolescent Psychiatry demonstrates that children who were abandoned to institutional care have an increased risk for behaviors similar to those seen in children with autism, including impaired social communication.
Obese and very obese patients have a lower risk of dying after they have been treated for heart attacks than do normal weight patients, according to research published in the European Heart Journal today (Wednesday 20 June).
"Lawyers for health insurers and the state sparred in court yesterday over regulators' rejection of 235 proposed rate increases, and a judge said he would decide by Monday whether the companies will be allowed to charge the higher prices." The insurers are arguing that the state's insurance commissioner overstepped his authority in rejecting the 235 of 274 requests to increase premiums (Weisman, 4/9).
› Verified 2 days ago
| Entity Name | Advanced Anesthesia Specialists A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871733600 PECOS PAC ID: 0042340705 Enrollment ID: O20100608000088 |
News Archive
NeuroSigma, Inc., a California-based life-sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that it has received approval from the Therapeutic Goods Administration to market its Monarch eTNS System in Australia.
A recent study published in the February 2015 issue of the Journal of the American Academy of Child and Adolescent Psychiatry demonstrates that children who were abandoned to institutional care have an increased risk for behaviors similar to those seen in children with autism, including impaired social communication.
Obese and very obese patients have a lower risk of dying after they have been treated for heart attacks than do normal weight patients, according to research published in the European Heart Journal today (Wednesday 20 June).
"Lawyers for health insurers and the state sparred in court yesterday over regulators' rejection of 235 proposed rate increases, and a judge said he would decide by Monday whether the companies will be allowed to charge the higher prices." The insurers are arguing that the state's insurance commissioner overstepped his authority in rejecting the 235 of 274 requests to increase premiums (Weisman, 4/9).
› Verified 2 days ago
| Entity Name | Justin S Tobias M D Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760727366 PECOS PAC ID: 5890949440 Enrollment ID: O20130206000375 |
News Archive
NeuroSigma, Inc., a California-based life-sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that it has received approval from the Therapeutic Goods Administration to market its Monarch eTNS System in Australia.
A recent study published in the February 2015 issue of the Journal of the American Academy of Child and Adolescent Psychiatry demonstrates that children who were abandoned to institutional care have an increased risk for behaviors similar to those seen in children with autism, including impaired social communication.
Obese and very obese patients have a lower risk of dying after they have been treated for heart attacks than do normal weight patients, according to research published in the European Heart Journal today (Wednesday 20 June).
"Lawyers for health insurers and the state sparred in court yesterday over regulators' rejection of 235 proposed rate increases, and a judge said he would decide by Monday whether the companies will be allowed to charge the higher prices." The insurers are arguing that the state's insurance commissioner overstepped his authority in rejecting the 235 of 274 requests to increase premiums (Weisman, 4/9).
› Verified 2 days ago
| Entity Name | 16th Street Anesthesia Services Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285101824 PECOS PAC ID: 0446585301 Enrollment ID: O20190715001713 |
News Archive
NeuroSigma, Inc., a California-based life-sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that it has received approval from the Therapeutic Goods Administration to market its Monarch eTNS System in Australia.
A recent study published in the February 2015 issue of the Journal of the American Academy of Child and Adolescent Psychiatry demonstrates that children who were abandoned to institutional care have an increased risk for behaviors similar to those seen in children with autism, including impaired social communication.
Obese and very obese patients have a lower risk of dying after they have been treated for heart attacks than do normal weight patients, according to research published in the European Heart Journal today (Wednesday 20 June).
"Lawyers for health insurers and the state sparred in court yesterday over regulators' rejection of 235 proposed rate increases, and a judge said he would decide by Monday whether the companies will be allowed to charge the higher prices." The insurers are arguing that the state's insurance commissioner overstepped his authority in rejecting the 235 of 274 requests to increase premiums (Weisman, 4/9).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Maricel A Isidro-reighard, CRNA Po Box 7096, Stockton, CA 95267-0096 Ph: (209) 956-7725 | Dr Maricel A Isidro-reighard, CRNA 1700 Mount Vernon Ave, Anesthesia Department, Bakersfield, CA 93306-4018 Ph: (661) 578-7273 |
News Archive
NeuroSigma, Inc., a California-based life-sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that it has received approval from the Therapeutic Goods Administration to market its Monarch eTNS System in Australia.
A recent study published in the February 2015 issue of the Journal of the American Academy of Child and Adolescent Psychiatry demonstrates that children who were abandoned to institutional care have an increased risk for behaviors similar to those seen in children with autism, including impaired social communication.
Obese and very obese patients have a lower risk of dying after they have been treated for heart attacks than do normal weight patients, according to research published in the European Heart Journal today (Wednesday 20 June).
"Lawyers for health insurers and the state sparred in court yesterday over regulators' rejection of 235 proposed rate increases, and a judge said he would decide by Monday whether the companies will be allowed to charge the higher prices." The insurers are arguing that the state's insurance commissioner overstepped his authority in rejecting the 235 of 274 requests to increase premiums (Weisman, 4/9).
› Verified 2 days ago
Mr. Bryan Elrod, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1700 Mount Vernon Ave, Bakersfield, CA 93306 Phone: 661-326-2000 | |
Alan Kim, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 11704 Nantwick Ct, Bakersfield, CA 93311 Phone: 714-269-0275 | |
Mr. Randy C. Willeby, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1700 Mount Vernon Ave, Bakersfield, CA 93306 Phone: 661-326-2128 Fax: 661-326-2129 | |
Lucille Petersen, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1700 Mount Vernon Ave, Bakersfield, CA 93306 Phone: 661-326-2000 | |
Jane Fickes, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1700 Mount Vernon Ave, Bakersfield, CA 93306 Phone: 661-326-2000 | |
Sunita Bendale, MSN, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1700 Mount Vernon Ave, Bakersfield, CA 93306 Phone: 661-326-2000 | |
Muhammad Murtaza Rizvi, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1700 Mount Vernon Ave, Bakersfield, CA 93306 Phone: 714-270-6337 |